SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-24-013981
Filing Date
2024-04-08
Accepted
2024-04-08 19:42:33
Documents
2
Period of Report
2024-04-05

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1608
2 ex24.htm EX-24 8364
  Complete submission text file 0001493152-24-013981.txt   11362
Mailing Address 315 MADISON AVE NEW YORK NY 10017
Business Address
Mack Gene (Reporting) CIK: 0001737979 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40237 | Film No.: 24830858

Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Issuer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)